Since 2013, CO*RE has delivered REMS-compliant, high-quality education to more than 515,000+ clinicians through 800+ accredited CE/CME activities (as of October 2024). Our in-person and online programs are designed to ensure consistency, effectiveness, and real-world applicability.
CO*RE uses a Common Outcomes Framework to align the FDA Blueprint with our learning objectives, content, and assessment questions—driving consistency and enabling rigorous impact analysis.
Using a custom outcomes dashboard, we aggregate data across partners to spot trends, close gaps, and rapidly iterate the curriculum. Key insights from our 2024 Outcomes Report include:
WHY WE’RE HERE
Navigating the terrain of pain management is a complex endeavor. The multifaceted challenges, particularly from nonmedical use of opioids and opioid use disorder, have cast a long shadow on our nation’s public health. In response, the Food & Drug Administration (FDA) has intensified efforts to ensure safer practices. CO*RE offers continuing education to healthcare professionals, aligning with the FDA Education Blueprint for Healthcare Providers Involved in the Treatment and Monitoring of Patients with Pain.
Notably, CO*RE has extended its reach, raising awareness of this public health imperative among over a million healthcare clinicians. This is our shared responsibility, a call to address this crisis with education, compassion, and unwavering commitment.
CO*RE MISSION STATEMENT
The CO*RE mission is to promote individual and population health and public safety through timely, evidence-based, outcome-oriented, and interprofessional education related to the comprehensive management of pain, substance use disorder, and their comorbidities.
FUNDER INFORMATION
This educational activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies.